In a world increasingly shaped by global health emergencies, it seems like we’re seeing the same playbook unfold again—this time with the virus known...
Last week, Moderna announced that it has received approval from the Food and Drug Administration (FDA) for the development of an mRNA vaccine for respiratory syncytial virus (RSV).
In a world increasingly shaped by global health emergencies, it seems like we’re seeing the same playbook unfold again—this time with the virus known as monkeypox.
Former Centers for Disease Control and Prevention (CDC) director Dr. Robert Redfield acknowledged that there are "significant" side effects from the COVID-19 vaccine.